Our last live virtual event of 2021: a quick scientific tea break with Communication Specialist Dr. Emma Gibbin-Lameira, is now available on demand! Watch as Dr. Gibbin-Lameira presents a powerful cytotoxicity case study showing Nanolive’s unique live cell-based testing and high content analysis in 96-well plate.
Specifically, Dr. Gibbin-Lameira has shown that:
- Multiplexed quantitative descriptors of cell morphology and composition at both the population (field of view) and single cell level can be combined with high spatio-temporal images to evaluate drug responses in parallel, over long periods of time
- It is possible to quantify dose-response effects of drugs on living cells in a multi-well set-up where different concentrations and different drugs can be tested in parallel.
Read our latest news
Nanolive – our story
Nanolive Nanolive delivers breakthrough imaging solutions that combine screening, imaging, and analysis to radically advance how scientists study living cells and provide novel biological insights into the mechanisms of cancer and neurodegenerative diseases. Our...
Feature Application: Calculating kinetic EC50 values from dose-response curves
Introduction Dose-response curves provide important pharmacodynamic properties (efficacy, potency, toxicity, and lethality) for evaluating the performance of candidate drugs in the discovery pipeline. Half maximal effective concentration (EC50) values are a standard...
Webinar: Generating kinetic EC50 values using label-free cytotoxicity assays
In this webinar, Dr. Emma Gibbin-Lameira will show how Nanolive’s label-free, non-invasive imaging can be used to quantify dose-dependent responses of HeLa cells to Chloroquine. Specifically, Dr. Gibbin-Lameira will show that: Dose-dependent experiments can be...
